Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 314 recruiting studies, sorted by proximity — each links to its official registry page
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Hartford Hospital (site 210) — Hartford, Connecticut (25.4 mi)
· Sponsor: VM Oncology, LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: NRG Oncology
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Collagen Matrix
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
Anterior Cruciate Ligament Reconstruction
N/A
Interventional 40 participants sought
University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Shockwave Medical, Inc.
Interoceptive Awareness and Function in Adolescents With Chronic Pain
Chronic Pain, Chronic Pain Syndrome
N/A
Observational 49 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Connecticut Children's Medical Center
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Starling Physicians — Hartford, Connecticut (25.4 mi)
· Sponsor: Pfizer
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (2.8 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hoffmann-La Roche
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: Pfizer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Shockwave Medical, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Burning Mouth Syndrome: Symptoms and Management
Burning Mouth Syndrome
EARLY/Phase 1
Interventional 50 participants sought
UMass Amherst — Amherst, Massachusetts (17.4 mi)
· Sponsor: University of Massachusetts, Amherst
A Type I Hybrid Effectiveness-Implementation Trial of MIO
Substance Use Disorder
N/A
Interventional 200 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Baystate Medical Center
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Hartford Healthcare — Hartford, Connecticut (25.4 mi)
· Sponsor: Parkinson's Foundation
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Vulvar Cancer, Sentinel Lymph Node
Phase 2
Interventional 157 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: University Medical Center Groningen
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Hartford, Connecticut (25.4 mi)
· Sponsor: Alkermes, Inc.
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Pulmonary Hypertension, Interstitial Lung Disease
N/A
Observational 80 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Liquidia Technologies, Inc.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Springfield, Massachusetts (2.8 mi)
· Sponsor: Axsome Therapeutics, Inc.
Sleep-dependent Learning in Aging
Sleep
N/A
Interventional 584 participants sought
University of Massachusetts — Amherst, Massachusetts (17.4 mi)
· Sponsor: University of Massachusetts, Amherst